| P2093 | author name string | Nita J Maihle | |
| | Blanca L Valle | |
| | Elsa M Cora | |
| | Lisandra Negron-Vega | |
| | Marianela Perez-Torres | |
| | Rene Nieves-Alicea | |
| P2860 | cites work | A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. | Q24533465 |
| | Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells | Q28235640 |
| | Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues | Q28277727 |
| | ADAMs: key components in EGFR signalling and development | Q28305519 |
| | Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4 | Q28609073 |
| | Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site | Q28646381 |
| | Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells | Q29616544 |
| | Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms. | Q30650378 |
| | Identification of a novel AU-Rich element in the 3' untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins | Q33967590 |
| | Drosophila rhomboid-1 defines a family of putative intramembrane serine proteases | Q34098885 |
| | Substrate specificity of rhomboid intramembrane proteases is governed by helix-breaking residues in the substrate transmembrane domain | Q34207965 |
| | Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2. | Q34309079 |
| | Matrix metalloproteinases: they're not just for matrix anymore! | Q34360566 |
| | Mechanism of intramembrane proteolysis investigated with purified rhomboid proteases. | Q34379351 |
| | A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor | Q34614751 |
| | Metalloproteinase inhibitors: biological actions and therapeutic opportunities. | Q34863959 |
| | CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling | Q35005223 |
| | Protein ectodomain shedding | Q35021911 |
| | The ADAMs family of metalloproteases: multidomain proteins with multiple functions | Q35039313 |
| | Proteolysis within the membrane: rhomboids revealed | Q35678316 |
| | Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. | Q35878888 |
| | The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer | Q36135007 |
| | Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. | Q36556065 |
| | A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells | Q36678230 |
| | Characterization of Glycosylation Sites of the Epidermal Growth Factor Receptor | Q37396323 |
| | Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process | Q37414612 |
| | Identification of serum factor inducing ectodomain shedding of proHB-EGF and sStudies of noncleavable mutants of proHB-EGF. | Q38300911 |
| | The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading | Q38320220 |
| | Regulated intracellular ligand transport and proteolysis control EGF signal activation in Drosophila | Q39583868 |
| | Soluble receptors for cytokines and growth factors: generation and biological function | Q40656511 |
| | EGF receptor expression, regulation, and function in breast cancer | Q40665432 |
| | Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme | Q40774834 |
| | Membrane-anchored growth factors. | Q40856819 |
| | EGFR family-mediated signal transduction in the human keratinocyte cell line HaCaT. | Q40922182 |
| | EGF-induced programmed cell death of human mammary carcinoma MDA-MB-468 cells is preceded by activation AP-1. | Q41051794 |
| | Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. | Q41199229 |
| | Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes | Q41602632 |
| | Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells. | Q41701569 |
| | Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades | Q41708821 |
| | Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin. | Q42540708 |
| | Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation | Q42810137 |
| | Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy | Q43851616 |
| | Linear non-competitive inhibition of solubilized human gamma-secretase by pepstatin A methylester, L685458, sulfonamides, and benzodiazepines | Q44033487 |
| | Generation and characterization of polyclonal antibodies specific for human p110 sEGFR. | Q44091925 |
| | Production of an Epidermal Growth Factor Receptor-Related Protein | Q44454765 |
| | Endocytosis-independent mechanisms of Delta ligand proteolysis | Q46951847 |
| | Properties of pervanadate and permolybdate. Connexin43, phosphatase inhibition, and thiol reactivity as model systems. | Q52243093 |
| | Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. | Q52829599 |
| | Monoclonal Antibodies Specific for Peptide Epitopes of the Epidermal Growth Factor Receptor's Extracellular Domain | Q53442709 |
| | MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. | Q54451512 |
| | The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGF alpha into soluble growth factor | Q67975102 |
| | Cell surface localization of proteolysis of human endothelial angiotensin I-converting enzyme. Effect of the amino-terminal domain in the solubilization process | Q71585920 |
| | Conformation of the transmembrane domain of the epidermal growth factor receptor | Q72688309 |
| | TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3 | Q77357145 |
| | An essential role for ectodomain shedding in mammalian development | Q77544828 |
| | A sandwich type acridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human sera | Q77609274 |
| | Epidermal growth factor receptor transmembrane domain: 2H NMR implications for orientation and motion in a bilayer environment | Q77648611 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 2907-2918 | |
| P577 | publication date | 2008-07-25 | |
| P1433 | published in | Experimental Cell Research | Q1524289 |
| P1476 | title | Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells | |
| P478 | volume | 314 | |